Cspc Pharmaceutical traded at 10.52 this Friday February 20th, increasing 0.27 or 2.63 percent since the previous trading session. Looking back, over the last four weeks, Cspc Pharmaceutical gained 6.37 percent. Over the last 12 months, its price rose by 109.98 percent. Looking ahead, we forecast Cspc Pharmaceutical to be priced at 10.28 by the end of this quarter and at 9.61 in one year, according to Trading Economics global macro models projections and analysts expectations.
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.